Lowering Cost and Increasing Access to Drugs Without Jeopardizing Innovation.
Publication
, Journal Article
Califf, RM; Slavitt, A
Published in: JAMA
April 23, 2019
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
April 23, 2019
Volume
321
Issue
16
Start / End Page
1571 / 1573
Location
United States
Related Subject Headings
- Prescription Drugs
- General & Internal Medicine
- Drug Costs
- Cost Control
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Califf, R. M., & Slavitt, A. (2019). Lowering Cost and Increasing Access to Drugs Without Jeopardizing Innovation. JAMA, 321(16), 1571–1573. https://doi.org/10.1001/jama.2019.3846
Califf, Robert M., and Andrew Slavitt. “Lowering Cost and Increasing Access to Drugs Without Jeopardizing Innovation.” JAMA 321, no. 16 (April 23, 2019): 1571–73. https://doi.org/10.1001/jama.2019.3846.
Califf RM, Slavitt A. Lowering Cost and Increasing Access to Drugs Without Jeopardizing Innovation. JAMA. 2019 Apr 23;321(16):1571–3.
Califf, Robert M., and Andrew Slavitt. “Lowering Cost and Increasing Access to Drugs Without Jeopardizing Innovation.” JAMA, vol. 321, no. 16, Apr. 2019, pp. 1571–73. Pubmed, doi:10.1001/jama.2019.3846.
Califf RM, Slavitt A. Lowering Cost and Increasing Access to Drugs Without Jeopardizing Innovation. JAMA. 2019 Apr 23;321(16):1571–1573.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
April 23, 2019
Volume
321
Issue
16
Start / End Page
1571 / 1573
Location
United States
Related Subject Headings
- Prescription Drugs
- General & Internal Medicine
- Drug Costs
- Cost Control
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences